For this reason, we decided to functionalize GNP with the half chain of an anti-human antibody directed towards CD44, a glycoprotein expressed at high rate by (myo-)fibroblasts that are the main players of bronchiolar obliteration in BOS patients. Here, CD44 is linked to Buschke-Ollendorff syndrome.